Specifically, we identified Brd4 as a key upstream regulator in our dataset, which correlates with an extensive body of literature describing Brd4 as a regulator of the oestrogen response genes in both endometrial and breast cancer [19,28]. Here, BRD4 is linked to breast carcinoma.